article thumbnail

Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology

DAIC

The company recently announced it has received CMS approval for Medicare coverage during the DRAIN-HF pivotal trial. For more information: www.procyrion.com If you enjoy this content, please share it with a colleague

article thumbnail

Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2

Circulation

Here, we aimed to evaluate the role and mechanism of Nrf3 in injury-induced pathological cardiac remodeling.METHODS:Global (Nrf3-KO) and CM-specific (Nrf3CM) Nrf3 knockout mice were subjected to MI or ischemia/reperfusion injury, followed by functional and histopathological analysis.